Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| abrdn Healthcare InvestorsHQH · Entity 8816 | Director · President | September 25, 2023 | September 25, 2023 |
| abrdn Healthcare Opportunities FundTHQ · Entity 5102 | Director · President | March 17, 2020 | March 17, 2020 |
| abrdn Life Sciences InvestorsHQL · Entity 8835 | Director · President | September 25, 2023 | September 25, 2023 |
| abrdn World Healthcare FundTHW · Entity 5390 | Director · President | April 06, 2021 | April 08, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
abrdn Healthcare Investors
Report date September 25, 2023 · Filed September 25, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 178,268.56 |
Reported balance
After 2023-09-25 transaction · row 1
1 source rowRow 1 · 2023-09-25 · Purchase · Acquired 9,500 · Balance 178,268.56 |
abrdn Healthcare Opportunities Fund
Report date March 17, 2020 · Filed March 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 31,202 |
Reported balance
After 2020-03-17 transaction · row 1
1 source rowRow 1 · 2020-03-17 · Purchase · Acquired 7,300 · Balance 31,202 |
abrdn Life Sciences Investors
Report date September 25, 2023 · Filed September 25, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 197,518.03 |
Reported balance
After 2023-09-25 transaction · row 1
1 source rowRow 1 · 2023-09-25 · Purchase · Acquired 10,096 · Balance 197,518.03 |
abrdn World Healthcare Fund
Report date April 06, 2021 · Filed April 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 30,768 |
Reported balance
After 2021-04-06 transaction · row 1
1 source rowRow 1 · 2021-04-06 · Other · Acquired 6,442 · Balance 30,768 |
| Subscription RightsSEC Table II · derivative / convertible security · Conversion / exercise price $14.26 · Expires 2021-04-06 | Direct | 0 |
Reported balance
After 2021-04-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-06 · Other · Disposed 24,326 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2023 Filed Sep 25, 2023 21:34 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 9,500 | $15.63 | $148,515.40 |
DisclosureSEC source: 0001104659-23-103574 · tm2326853-1_4seq1.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,268.56 Read SEC document |
| September 25, 2023 Filed Sep 25, 2023 21:35 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 10,096 | $12.39 | $125,115.69 |
DisclosureSEC source: 0001104659-23-103576 · tm2326853-2_4seq1.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,518.03 Read SEC document |
| September 20, 2023 Filed Sep 20, 2023 22:39 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 9,500 | $15.88 | $150,828.65 |
DisclosureSEC source: 0001104659-23-102458 · tm2326608d1_4seq1.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,768.56 Read SEC document |
| September 20, 2023 Filed Sep 20, 2023 22:40 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 12,000 | $12.68 | $152,205.60 |
DisclosureSEC source: 0001104659-23-102460 · tm2326608-2_4seq1.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,422.03 Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 15:40 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 6,403 | $21.63 | $138,496.89 |
DisclosureSEC source: 0001104659-21-103959 · tm2124858-1_4seq1.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,489.44 Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:25 UTC | abrdn World Healthcare Fund THW · Entity 5390 | OtherSubscription Rights · Derivative | 24,326 | $0.00 Strike: $14.26 | $0.00 |
DisclosureSEC source: 0001104659-21-048071 · tm2111500-2_4seq1.xml · derivative · entry 2 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Shares of Beneficial Interest · 6,442 shares Expires 2021-04-06 Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:25 UTC | abrdn World Healthcare Fund THW · Entity 5390 | OtherShares of Beneficial Interest | 6,442 | $14.26 | $91,875.80 |
DisclosureSEC source: 0001104659-21-048071 · tm2111500-2_4seq1.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,768 Read SEC document |
| October 26, 2020 Filed Oct 26, 2020 21:26 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 5,200 | $20.53 | $106,744.04 |
DisclosureSEC source: 0001104659-20-118219 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,411.02 Read SEC document |
| October 26, 2020 Filed Oct 26, 2020 21:27 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 6,175 | $17.52 | $108,203.91 |
DisclosureSEC source: 0001104659-20-118221 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,835.8 Read SEC document |
| October 21, 2020 Filed Oct 21, 2020 23:16 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 5,050 | $20.68 | $104,427.44 |
DisclosureSEC source: 0001104659-20-116859 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,211.02 Read SEC document |
| October 21, 2020 Filed Oct 21, 2020 23:18 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 5,950 | $17.75 | $105,605.96 |
DisclosureSEC source: 0001104659-20-116861 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,660.8 Read SEC document |
| May 21, 2020 Filed May 22, 2020 15:04 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 5,000 | $21.01 | $105,054.00 |
DisclosureSEC source: 0001104659-20-065198 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,357.38 Read SEC document |
| May 21, 2020 Filed May 22, 2020 15:05 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 5,950 | $17.74 | $105,556.57 |
DisclosureSEC source: 0001104659-20-065199 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,820.99 Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 22:25 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 6,800 | $16.24 | $110,411.60 |
DisclosureSEC source: 0001104659-20-034865 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,318.65 Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 22:25 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseShares of Beneficial Interest | 8,300 | $13.27 | $110,106.97 |
DisclosureSEC source: 0001104659-20-034866 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,813.88 Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 18:24 UTC | abrdn World Healthcare Fund THW · Entity 5390 | PurchaseShares of Beneficial Interest | 9,926 | $10.77 | $106,931.81 |
DisclosureSEC source: 0001104659-20-034864 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,326 Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 18:25 UTC | abrdn Healthcare Opportunities Fund THQ · Entity 5102 | PurchaseShares of Beneficial Interest | 7,300 | $14.67 | $107,103.41 |
DisclosureSEC source: 0001104659-20-034867 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,202 Read SEC document |
| December 26, 2018 Filed Dec 26, 2018 22:24 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 6,300 | $17.14 | $107,970.66 |
DisclosureSEC source: 0001104659-18-074725 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,406.1956 Read SEC document |
| December 26, 2018 Filed Dec 26, 2018 17:24 UTC | abrdn World Healthcare Fund THW · Entity 5390 | PurchaseShares of Beneficial Interest | 9,400 | $11.11 | $104,410.50 |
DisclosureSEC source: 0001104659-18-074724 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,400 Read SEC document |
| October 25, 2018 Filed Oct 25, 2018 18:53 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 5,500 | $20.43 | $112,344.10 |
DisclosureSEC source: 0001104659-18-063922 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,106.1956 Read SEC document |
| October 25, 2018 Filed Oct 25, 2018 14:53 UTC | abrdn Healthcare Opportunities Fund THQ · Entity 5102 | PurchaseShares of Beneficial Interest | 6,000 | $17.43 | $104,580.00 |
DisclosureSEC source: 0001104659-18-063921 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,902 Read SEC document |
| October 17, 2018 Filed Oct 17, 2018 19:59 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseShares of Beneficial Interest | 3,882 | $21.78 | $84,534.43 |
DisclosureSEC source: 0001104659-18-062503 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,606.1956 Read SEC document |
| October 17, 2018 Filed Oct 17, 2018 15:59 UTC | abrdn Healthcare Opportunities Fund THQ · Entity 5102 | PurchaseShares of Beneficial Interest | 5,902 | $18.19 | $107,373.91 |
DisclosureSEC source: 0001104659-18-062504 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,902 Read SEC document |
| October 11, 2018 Filed Oct 11, 2018 13:20 UTC | abrdn Healthcare Opportunities Fund THQ · Entity 5102 | PurchaseShares of Beneficial Interest | 5,500 | $17.59 | $96,759.85 |
DisclosureSEC source: 0001104659-18-061572 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| October 10, 2018 Filed Oct 10, 2018 15:57 UTC | abrdn Healthcare Opportunities Fund THQ · Entity 5102 | PurchaseShares of Beneficial Interest | 5,500 | $18.27 | $100,466.85 |
DisclosureSEC source: 0001104659-18-061368 · a4.xml · nonDerivative · entry 1 OMSTEAD DANIEL R · CIK 0001254774 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.